论文部分内容阅读
目的:研究分析通心络胶囊应用于社区冠心病患者治疗中的效果。方法:选取社区中90例冠心病患者,随机分为对照组和观察组,每组各45人。其中对照组予以常规治疗,观察组则在常规治疗基础上予以通心络胶囊予以治疗。对比两组患者的效果。结果:两组患者经治疗后,观察组患者治疗有效的有42例(93.33%),对照组患者治疗有效的有39例(86.67%),观察组患者治疗有效率明显高于对照组(P<0.05)。两组在治疗前PWV值无显著差异(P>0.05);经治疗后,观察组患者的PWV值明显优于对照组(P<0.05),具有统计学意义。结论:应用通心络胶囊治疗冠心病患者,能够有效改善患者症状,提高患者生活质量,在临床治疗中具有重要意义,值得推广及应用。
Objective: To study the effect of Tongxinluo capsule in the treatment of community-based coronary heart disease patients. Methods: Ninety patients with coronary heart disease in the community were selected and randomly divided into control group and observation group, with 45 in each group. The control group was given routine treatment, while the observation group was treated with Tongxinluo capsule on the basis of routine treatment. Compare the effect of two groups of patients. Results: After treatment, 42 patients (93.33%) in the observation group and 39 (86.67%) patients in the control group were treated effectively, and the treatment efficiency in the observation group was significantly higher than that in the control group <0.05). There was no significant difference in PWV between the two groups before treatment (P> 0.05). After treatment, the PWV of the observation group was significantly better than that of the control group (P <0.05), with statistical significance. Conclusion: The application of Tongxinluo capsule in patients with coronary heart disease can effectively improve the symptoms and improve the quality of life of patients, which is of great significance in clinical treatment and worthy of promotion and application.